scispace - formally typeset
X

Xiaoyuan Chen

Researcher at National University of Singapore

Publications -  1270
Citations -  115993

Xiaoyuan Chen is an academic researcher from National University of Singapore. The author has contributed to research in topics: Photothermal therapy & Medicine. The author has an hindex of 149, co-authored 994 publications receiving 89870 citations. Previous affiliations of Xiaoyuan Chen include Brown University & University of Southern California.

Papers
More filters
Patent

Methods for high figure-of-merit in nanostructured thermoelectric materials

TL;DR: In this article, the properties of nanostructured thermoelectric materials with high ZT values are discussed, and various compositions and methods relating to aspects of these materials (e.g., modulation doping) are further disclosed.
Journal ArticleDOI

The manipulation of natural killer cells to target tumor sites using magnetic nanoparticles.

TL;DR: Cy5.5 conjugated Fe(3)O(4)/SiO(2) core/shell nanoparticles could allow us to control movement of human natural killer cells (NK-92MI) by an external magnetic field and enhanced infiltration of immunology to the target site.
Journal ArticleDOI

Targeted therapeutic nanotubes influence the viscoelasticity of cancer cells to overcome drug resistance.

TL;DR: The newly developed CAHA-sSWCNT-DOX nanoformula, which delivers therapeutics and acts as a sensitizer to influence drug uptake and induce apoptosis with minimal resistance factor, provides a novel effective means of counteracting the phenomenon of multidrug resistance.
Journal ArticleDOI

The genotype-dependent influence of functionalized multiwalled carbon nanotubes on fetal development

TL;DR: It is reported that intravenous injections of multi-walled carbon nanotubes into p53 (a well-known cancer-susceptible gene) heterozygous pregnant mice can induce p53- dependent responses in fetal development and suggest that CNTs might have genetic background-dependent toxic effect on the normal development of the embryo.
Journal ArticleDOI

Bench to Bedside: Albumin Binders for Improved Cancer Radioligand Therapies.

TL;DR: This Review discusses recent advances in albumin binder platforms used in RLT, with an emphasis on 4-( p-iodophenyl)butyric acid and Evans blue derivatives and four biological systems pertinent to oncology that utilize this class of compounds.